Pediatric bipolar major depression: Choosing treatment
- David Axelson, MD
David Axelson, MD
- Professor of Psychiatry
- The Ohio State University College of Medicine
Pediatric bipolar disorder often includes episodes of major depression. As an example, a four-year, prospective observational study of children and adolescents with bipolar disorder (n = 413) found that they were ill with major depression for 6 percent of the follow-up time, and ill with subsyndromal depressive symptoms for another 12 percent of the time .
This topic reviews choosing treatment for pediatric bipolar major depression. Other aspects pediatric bipolar disorder are discussed separately, including an overview of choosing treatment; general principles of using pharmacotherapy; the efficacy and core elements of adjunctive psychotherapy; assessment and diagnosis; and the epidemiology, clinical features, and course of illness:To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Birmaher B, Axelson D, Goldstein B, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 2009; 166:795.
- Cosgrove VE, Roybal D, Chang KD. Bipolar depression in pediatric populations : epidemiology and management. Paediatr Drugs 2013; 15:83.
- Detke HC, DelBello MP, Landry J, et al. Olanzapine/fluoxetine combination in children and adolescents with bipolar I depression: A randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2015.
- Findling RL, Pathak S, Earley WR, et al. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 2014; 24:325.
- DelBello MP, Chang K, Welge JA, et al. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord 2009; 11:483.
- Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006; 45:298.
- Carandang CG, Maxwell DJ, Robbins DR, Oesterheld JR. Lamotrigine in adolescent mood disorders. J Am Acad Child Adolesc Psychiatry 2003; 42:750.
- Soutullo CA, Díez-Suárez A, Figueroa-Quintana A. Adjunctive lamotrigine treatment for adolescents with bipolar disorder: retrospective report of five cases. J Child Adolesc Psychopharmacol 2006; 16:357.
- Patel NC, DelBello MP, Bryan HS, et al. Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006; 45:289.
- Wozniak J, Faraone SV, Chan J, et al. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study. J Clin Psychiatry 2015; 76:1548.
- Findling RL, McNamara NK, Gracious BL, et al. Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 2003; 42:895.
- Kowatch RA, Sethuraman G, Hume JH, et al. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003; 53:978.
- Biederman J, Mick E, Spencer TJ, et al. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 2000; 10:185.
- Sit D, Wisner KL, Hanusa BH, et al. Light therapy for bipolar disorder: a case series in women. Bipolar Disord 2007; 9:918.
- Swedo SE, Allen AJ, Glod CA, et al. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:816.
- Dauphinais DR, Rosenthal JZ, Terman M, et al. Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression. Psychiatry Res 2012; 196:57.
- McClellan J, Kowatch R, Findling RL, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:107.
- Ghaziuddin N, Kutcher SP, Knapp P, et al. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry 2004; 43:1521.
- Connor DF. Electroconvulsive therapy, transcranial magnetic stimulation, and deep brain stimulation. In: Dulcan's Textbook of Child and Adolescent Psychiatry, Dulcan MK. (Ed), American Psychiatric Publishing, Inc, Washington, DC 2010. p.795.
- Walter G, Rey JM. Has the practice and outcome of ECT in adolescents changed? findings from a whole-population study. J ECT 2003; 19:84.
- Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry 1997; 154:595.
- Stein D, Weizman A, Bloch Y. Electroconvulsive therapy and transcranial magnetic stimulation: can they be considered valid modalities in the treatment of pediatric mood disorders? Child Adolesc Psychiatr Clin N Am 2006; 15:1035.
- Geller B, Craney JL, Bolhofner K, et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2002; 159:927.
- Scheffer RE, Tripathi A, Kirkpatrick FG, Schultz T. Guidelines for treatment-resistant mania in children with bipolar disorder. J Psychiatr Pract 2011; 17:186.
- Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord 2004; 82:149.
- Baumer FM, Howe M, Gallelli K, et al. A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene. Biol Psychiatry 2006; 60:1005.